Retractable Technologies
Retractable Technologies designs, manufactures, and markets automated retraction safety medical devices, including VanishPoint syringes and EasyPoint needles, for healthcare facilities. The company serves hospitals, clinics, and alternate care markets through distributors, GPOs, and an Abbott Labs partnership.
- Company typePublic
- Founded1989
- HeadquartersLittle Elm, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Retractable Technologies does
Retractable Technologies, Inc. is a U.S.-based medical device company founded in 1989 and headquartered in Little Elm, Texas, that designs, develops, manufactures, and markets safety medical devices for the healthcare profession. The company is publicly traded on NYSE American under ticker RVP and reported FY2025 revenue of approximately $38.3 million, up 15.8% year-over-year, though it has incurred operating losses in each of the past three reported years. Its core technology is a patented automated retraction mechanism based on a friction ring that causes contaminated needles to retract automatically from the patient into the device barrel after use, eliminating healthcare worker exposure to accidental needlestick injuries.
The product portfolio spans the VanishPoint line (safety syringes, insulin syringes, blood collection sets, IV catheters), the EasyPoint line (retractable needles compatible with luer lock, luer slip, and prefilled syringes), the Patient Safe syringe (designed to reduce bloodstream infections from catheter hub contamination), and PerfectPoint needle technology (improved sharpness and tip integrity). Distribution is multi-channel: Abbott Laboratories holds exclusive rights to VanishPoint in U.S. acute care hospitals and anesthesia trays; specialty and general line distributors serve the alternate care market; group purchasing organizations including CCPA Purchasing Partners and Vizient extend reach into physician practices and large hospital systems; and international distributors operate across Europe, Africa, and Japan.
The business model is hardware sales of safety devices, supplemented by modest licensing royalty income. Domestically, Retractable is shifting production capacity from China-based manufacturing (historically via a partnership with Double Dove Co. at an 8.5-cent average unit cost) toward its Little Elm facility in response to 120% tariffs on Chinese syringe and needle imports as of March 2026. This transition drove a 16% workforce reduction in April 2026 targeting approximately $2.2 million in annual savings, while Q1 2026 results showed a 13% revenue decline offset by 42.4% international growth and 3.6% unit volume growth, indicating mix shift rather than demand collapse.
Retractable Technologies firmographics
Firmographics- Name
- Retractable Technologies
- Legal name
- Retractable Technologies, Inc.
- Website
- https://retractable.com
- Company type
- Public
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Retractable Technologies designs, manufactures, and markets automated retraction safety medical devices, including VanishPoint syringes and EasyPoint needles, for healthcare facilities. The company serves hospitals, clinics, and alternate care markets through distributors, GPOs, and an Abbott Labs partnership.
- Ownership category
- akta.pro rank
Retractable Technologies industry classification
Industry- Product category
- Safety Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Prefilled Syringes & Safety Syringes (HLAHAIAA)
- akta.pro secondary industry
- Sharps Safety, Needlestick Prevention & Disposal (Safety Devices, Sharps Containers) (HLAHANAH)
Keywords
Where Retractable Technologies is headquartered
LocationHeadquarters
- HQ city
- Little Elm
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Retractable Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
Revenue model
- Medical Device Sales: Revenue generated from the sale of safety medical devices including VanishPoint syringes, EasyPoint needles, blood collection devices, and IV catheters. Products are sold through distributors, GPOs, and direct relationships with healthcare facilities. Domestic revenues increased 9.7% due to higher VanishPoint and EasyPoint needle sales. International revenues increased 64.0% due to higher EasyPoint needle sales.
- Royalty Revenue: The company receives royalty payments from licensed technology. Royalty expense decreased 7.0% due to decrease in gross sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Group purchasing organization pricing through CCPA Purchasing Partners |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels8 records
Retractable Technologies product offering
Product offeringCore offering
Retractable Technologies designs, develops, manufactures, and markets safety medical devices for the healthcare profession. Its core offerings are VanishPoint and EasyPoint syringes, needles, blood collection devices, and IV catheters featuring patented automated retraction technology that retracts contaminated needles into the device barrel after use to prevent needlestick injuries. Products are sold to hospitals, clinics, physician offices, and international healthcare markets through distributors and group purchasing organizations.
Product overview
Retractable Technologies offers a portfolio of safety medical devices featuring automated retraction technology designed to prevent needlestick injuries and reduce healthcare costs. The core product line includes the VanishPoint Syringe, VanishPoint Insulin Syringe, EasyPoint Retractable Needle, EasyPoint Blood Collection Tube Holder with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. These products work by automatically retracting the contaminated needle into the syringe barrel after use, eliminating exposure to used needles. The company also offers the Patient Safe Syringe for bloodstream infection prevention and the PerfectPoint needle technology for enhanced sharpness and patient comfort. All devices are distributed through specialty and general line distributors to acute care hospitals and alternate care markets.
Differentiator
Problem solved
Functional benefit
Brands
- VanishPoint: Automated retraction safety syringes and blood collection devices designed to prevent needlestick injuries by retracting the needle directly from the patient into the barrel.
- EasyPoint
- Patient Safe
- PerfectPoint
Products and services
- VanishPoint Syringe Automated retraction safety syringe that retracts the contaminated needle directly from the patient into the barrel of the device using patented friction ring technology, requiring single-handed passive activation with no additional steps. Designed for healthcare workers performing injections, immunizations, and general-purpose clinical use in hospitals and clinics.
- VanishPoint Insulin Syringe U-100 insulin syringe with automated retraction technology that provides an optimum view of the syringe scale for accurate dose preparation and delivery. Used by diabetic patients and clinicians for insulin administration with built-in safety protection.
- EasyPoint Retractable Needle Retractable needle featuring automated pre-removal retraction compatible with luer lock syringes, luer slip syringes, and prefilled syringes. Used for injections, fluid aspiration, and blood collection in healthcare facilities, with industry-standard safety performance.
- EasyPoint Blood Collection Tube Holder with Needle Blood collection device that allows in-vein activation, effectively reducing exposure to the contaminated needle. Both ends of the blood-filled needle are safely enclosed when retracted. Designed for phlebotomy and blood collection workflows in hospitals and clinical laboratories.
- VanishPoint Blood Collection Set Blood collection device providing automated in-vein retraction and one-handed activation to effectively reduce the risk of needlestick injuries. Used by healthcare workers performing venipuncture and blood draws in clinical settings.
- VanishPoint IV Catheter IV catheter with automated retraction that does not require additional components such as sliding sheaths, metal clips, or activation buttons. Designed for peripheral venous access in hospitals and clinical environments with passive safety protection.
- Patient Safe Syringe Safety syringe uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Intended for clinical use in catheter-based procedures and applications where infection prevention is a priority.
- PerfectPoint Needle Technology Needle technology providing superior sharpness with lower penetration force and maintained tip integrity after vial penetration, eliminating the time and expense of needle changing. Designed for use across clinical injection and aspiration applications requiring enhanced patient comfort and workflow efficiency.
Quantifiable outcome
- 57% less space in sharps containers compared to competitor products
- +3 more outcomes
Companies that use Retractable Technologies
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Retractable Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Retractable Technologies partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and regional.
- CCPA Purchasing PartnerscoreGroup purchasing organization (GPO) contracted to provide discounted pricing on Retractable Technologies' VanishPoint Syringe and EasyPoint Retractable Needle to its physician members. The agreement covers products featuring automated retraction technology designed to reduce needlestick injuries and disposal costs by approximately 40%. Members access products through CCPAPP's negotiated pricing structure.
- VizientcoreVizient, the largest healthcare performance improvement company in the country, awarded Innovative Technology designation to Retractable Technologies' EasyPoint Blood Collection Tube Holder with Needle. Healthcare experts serving on Vizient committees evaluated the technology for its potential to improve patient care and safety outcomes.
- B. Braun SubsidiaryregionalThree-year agreement with B. Braun subsidiary to distribute VanishPoint safety needle devices in Africa. Represents strategic expansion into African markets for syringe safety technology.
- Biocare NordicregionalCopenhagen-based medical supply firm engaged to distribute VanishPoint safety needle devices to healthcare facilities in Denmark. Partner spent nearly a year evaluating VanishPoint devices in customer facilities before signing agreement.
- Eurocept Pharmaceuticals BVregionalAmsterdam-based pharmaceutical company with sales operations in the Benelux countries engaged to distribute VanishPoint safety needle devices. Managing director Mike van Woensel noted VanishPoint devices will be prioritized in sales calls to home care and hospital customers.
- Labdesign ABregionalStockholm-based medical marketing firm engaged to distribute VanishPoint safety needle devices in Sweden. Managing director Thomas Busch noted Sweden is taking the lead in Europe in providing citizens with the safest technology available.
- Double Dove Co., Ltd.coreManufacturing agreement with leading syringe manufacturer in China to produce VanishPoint devices for worldwide distribution. Double Dove supplies VanishPoint syringes at average unit cost of 8.5 cents, fully packaged, sterilized and ready for use. This partnership was critical for production capacity but has been impacted by tariffs, prompting increased domestic manufacturing efforts.
- Abbott LaboratoriescoreMarketing and distribution agreement granting Abbott exclusive right to place VanishPoint automated retraction syringes in spinal and epidural anesthesia trays marketed to acute care hospitals in the United States. Agreement includes use of 1cc and 3cc syringes in trays shipped to customers.
Scale indicators15 records
Recent moves6 records
Expansion highlights5 records
Retractable Technologies competitors and assessment
Company assessmentBroad incumbents
- B. Braun Medical: Global medical device and pharmaceutical company producing Inject syringes, Introcan Safety IV catheters, and a broad portfolio of safety injection devices. Distributes RTI's VanishPoint in Africa and competes in overlapping product categories globally.
- Becton Dickinson (BD): Global medical device leader that manufactures conventional and safety-engineered syringes and needles (BD SafetyGlide, BD Eclipse). RTI won a $100M antitrust settlement against BD in 2004, underscoring direct head-to-head competition in safety injection devices.
Direct peers
- Nipro Medical: Japanese medical device manufacturer producing syringes, needles, and blood collection devices including safety-engineered variants. Comparable in automated retraction and passive safety mechanism categories.
- Smiths Medical: Now part of ICU Medical, Smiths Medical produces safety syringes, needles, and blood collection devices under the Jelco and Portex brands. Directly competes with VanishPoint and EasyPoint in acute care safety injection markets.
- Vygon: French medical device company manufacturing safety IV catheters, syringes, and blood collection devices for hospital and alternate care markets. Direct overlap with VanishPoint IV catheter and EasyPoint offerings.
- ICU Medical: Manufacturer of medical connectors, syringes, and needle-free injection systems acquired Smiths Medical. Competes with RTI across safety IV catheters, syringes, and blood collection devices in U.S. hospitals.
- Terumo: Global medical device manufacturer offering syringes, needles (including SurGuard3 safety needles), and blood collection products. Comparable in safety syringe technology and target hospital customers.
- Owen Mumford: UK-based medical device company specializing in safety injection devices (Unifine SafeClick, Unistik safety lancets). Comparable niche competitor in safety-engineered drug delivery for hospitals and alternate care.
Others
- Cardinal Health: Major U.S. medical product distributor that operates as a sales channel for competing safety syringe manufacturers. Relevant as a channel counterpart and indirect competitor for hospital contracts, though not a direct product peer.
Emerging players
- Sol-Millennium Medical Group: Growing manufacturer of safety syringes, needles, and sharps injury prevention devices. Competes with RTI in alternate care and immunization segments with a focus on cost-competitive offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Retractable Technologies social profiles
Digital presenceRetractable Technologies compliance and trust
Trust signalCompliance1 record
Retractable Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Retractable Technologies leadership team
Management profileNumber of profiles
Profiles2 records
Retractable Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Retractable Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Retractable Technologies
What does Retractable Technologies do?
Retractable Technologies designs, develops, manufactures, and markets safety medical devices for the healthcare profession. Its core offerings are VanishPoint and EasyPoint syringes, needles, blood collection devices, and IV catheters featuring patented automated retraction technology that retracts contaminated needles into the device barrel after use to prevent needlestick injuries. Products are sold to hospitals, clinics, physician offices, and international healthcare markets through distributors and group purchasing organizations.
Is Retractable Technologies a public or private company?
Retractable Technologies is a public company. It is classified as public and is currently operating.
When was Retractable Technologies founded?
Retractable Technologies was founded in 1989. It employs 101 to 250 people.
Where is Retractable Technologies based?
Retractable Technologies is headquartered in Little Elm, United States, in the North America region.
How does Retractable Technologies make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are royalty Revenue.
Who are Retractable Technologies's main competitors?
Broad incumbents on record are B. Braun Medical and Becton Dickinson (BD). Direct peers are Nipro Medical, Smiths Medical, Vygon, ICU Medical, Terumo and Owen Mumford. Cardinal Health is listed as an others. Sol-Millennium Medical Group is listed as an emerging player.
Does Retractable Technologies have an API?
No public API is recorded for Retractable Technologies.
What industry is Retractable Technologies in?
Retractable Technologies's product category is Safety Medical Devices. Its primary akta.pro industry code is HLAHAIAA, Prefilled Syringes & Safety Syringes, with a secondary code of HLAHANAH, Sharps Safety, Needlestick Prevention & Disposal (Safety Devices, Sharps Containers). Its NAICS code is 339112 and its SIC code is 3841.